TCIM
TBIO

TIAA CREF Investment Management’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

TIAA CREF Investment Management’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$291K Buy
28,525
+14,817
+108% +$114K ﹤0.01% 2786
2018
Q4 		$103K Hold
13,708
– – ﹤0.01% 2958
2018
Q3 		$137K Buy
+13,708
New +$160K ﹤0.01% 3020

Other funds holding TBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
AVA
Atlas Venture Advisors Boston, Massachusetts $143M AUM 25.68% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

TIAA CREF Investment Management's TBIO Position: Q1 2019 in Review

TIAA CREF Investment Management increased its Translate Bio, Inc. Common Stock (TBIO) stake by 108% in Q1 2019, buying an estimated $114K and bringing the position to 28,525 shares worth $291K. The position accounts for ﹤0.01% of the portfolio, ranked #2786.

TIAA CREF Investment Management first reported a position in TBIO in Q3 2018 and has held it in 3 quarters since. 52 funds tracked by Wall St. Rank hold TBIO as of Q1 2019.

  • TIAA CREF Investment Management held 28,525 shares of Translate Bio, Inc. Common Stock worth $291K as of Q1 2019.
  • TIAA CREF Investment Management bought 14,817 Translate Bio, Inc. Common Stock shares in Q1 2019, an estimated $114K.
  • Translate Bio, Inc. Common Stock made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #2786 holding.
  • TIAA CREF Investment Management first reported a position in Translate Bio, Inc. Common Stock in Q3 2018 and has held it in 3 quarters since.
  • 52 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.